Avantax Advisory Services, Inc. Vericel Corp Transaction History
Avantax Advisory Services, Inc.
- $14.9 Billion
- Q3 2024
A detailed history of Avantax Advisory Services, Inc. transactions in Vericel Corp stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 13,569 shares of VCEL stock, worth $766,648. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,569
Previous 8,938
51.81%
Holding current value
$766,648
Previous $410,000
39.76%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VCEL
# of Institutions
276Shares Held
48.5MCall Options Held
91.8KPut Options Held
23.2K-
Black Rock Inc. New York, NY8.06MShares$455 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.83MShares$216 Million3.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.48MShares$197 Million0.0% of portfolio
-
State Street Corp Boston, MA2.43MShares$137 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.37MShares$134 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.67B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...